Maynard Um
-
-
-
-
-
-
-
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
-
-
-
-
-
-
-
Kairos Pharma (KAPA) Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer
-
-
-
-
-
-
-
Kairos Pharma (KAPA) adds Huntsman Cancer Institute for ENV105 clinical trial phase 2
-
-
-
-
401,715 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

